STERIS plc Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Period Increase (Decrease)
STERIS plc (STE) reported Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Period Increase (Decrease) of $100.00 thousand for the 12-month period ending 2025-03-31, per its 10-K filed 2026-05-29.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationPeriodIncreaseDecrease · last filed 2026-05-29
- STERIS plc defined benefit plan, plan assets level 3 reconciliation, period increase (decrease) for fiscal 2025 was $100.00K, a 257.14% increase from fiscal 2024.
- STERIS plc defined benefit plan, plan assets level 3 reconciliation, period increase (decrease) for fiscal 2024 was $28.00K.
- STERIS plc defined benefit plan, plan assets level 3 reconciliation, period increase (decrease) for fiscal 2023 was -$157.00K.
- STERIS plc defined benefit plan, plan assets level 3 reconciliation, period increase (decrease) for fiscal 2022 was -$115.00K, a 158.38% decline from fiscal 2021.
| Period end | Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Period Increase (Decrease) 12 month |
|---|---|
| 2025-03-31 | $100.00K 10-K · filed 2026-05-29 |
| 2024-03-31 | $28.00K 10-K · filed 2025-05-29 |
| 2023-03-31 | -$157.00K 10-K · filed 2024-05-29 |
| 2022-03-31 | -$115.00K 10-K · filed 2023-05-26 |
| 2021-03-31 | $197.00K 10-K · filed 2022-05-31 |
| 2020-03-31 | $62.00K 10-K · filed 2021-05-28 |
| 2019-03-31 | $29.00K 8-K · filed 2021-02-09 |
| 2018-03-31 | -$43.00K 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |